Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

149 results about "Mucositis" patented technology

Mucositis is a condition characterised by pain and inflammation of the body's mucous membrane.

Therapeutic compositions and methods for managing treatment-related effects

Disclosed herein are methods and compositions for preventing or reducing adverse events associated with administration of a RAS(ON) inhibitors. Thus, disclosed are compositions and methods for treating or preventing RAS(ON) inhibitor therapy-associated rash or mucositis. The methods involve administering a compound that binds to cyclophilin A (CypA) to compete with a RAS(ON) inhibitor for CypA binding, thereby reducing tri-complex formation in non-tumor tissues. These approaches may improve the tolerability of RAS(ON) inhibitor therapies without compromising efficacy.
Owner:REVOLUTION MEDICINES INC

Systems, devices, and methods for reducing a temperature of a user's mouth and surrounding tissue

PCT designated stage expiredWO2024243457A1RespiratorsAnaesthesiaOral mucous membraneOral tissue
Mouth-cooling devices for absorbing heat from a user's mouth prior to, during, and / or after receiving treatment with chemotherapy may assist with reducing incidences of and / or mitigating pain and discomfort caused by oral mucositis that may result from receiving chemotherapy treatments. The mouth-cooling devices may include a plurality of components sized, shaped, and / or configured to fit within a users mouth to cool oral tissue from inside and / or outside the user's oral cavity. In some instances, the mouth-cooling devices may have a body configured to fit within the user's oral cavity proximate to tissue so that it may absorb heat from the tissue. The mouth-cooling devices may also have an external component coupled to the body. The external component may be sized, shaped, and / or configured to sit outside the user's mouth to absorb heat from the user's lips and / or cheeks.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Risk prediction model construction method for oral mucositis nursing

The invention relates to the technical field of data processing, in particular to a risk prediction model construction method for oral mucositis nursing, and the method comprises the steps: obtaining the data of all patients seeing a doctor; according to each risk factor of the patient under all the risk levels, obtaining an influence degree of the risk factor on the assessment risk level, and screening out a key risk factor of each risk level; according to the influence degree of each risk factor on all the assessment risk levels, the importance degree of each risk factor is obtained, and all important risk factors are screened out; and according to the key risk factors and the important risk factors of each risk level, constructing an oral mucositis risk prediction model. According to the method, the oral mucositis risk prediction model is constructed by analyzing historical patient data, so that the severity of the oral mucositis of the patient after chemotherapy is accurately predicted, and corresponding prevention and nursing are provided for the patient.
Owner:DEZHOU ZEYU MEDICAL DEVICE TECHNOLOGY CO LTD

External gel material for treating oral mucositis and preparation method thereof

The invention belongs to the technical field of medical materials, and discloses an external gel material for treating oral mucositis and a preparation method of the external gel material. The gel is temperature-sensitive slow-release antibacterial gel, adopts safe components, has a temperature-sensitive characteristic, is in a sol state in a low-temperature state, is convenient to smear, can be converted into a gel state when the temperature is close to the body temperature of a human body, can be tightly attached to an oral mucosa, is good in adhesiveness to the oral mucosa, can also slowly release drugs, and has relatively strong antibacterial performance; the repair and regeneration of oral mucosa epithelial tissues can be promoted. The gel can effectively act on the treatment process of oral diseases, is also suitable for daily oral care, and provides guarantee for oral health.
Owner:JIAMUSI UNIVERSITY

Adipose-derived stem cell and exosome composition for mucosal inflammation and application of adipose-derived stem cell and exosome composition

The invention relates to an adipose-derived stem cell and exosome composition for mucosal inflammation and an application of the adipose-derived stem cell and exosome composition. The composition is composed of a hybrid nano-vesicle and a pulsatilla chinensis exosome compound in a mass ratio of 1: 1. The hybrid nanovesicles are prepared by fusing adipose-derived stem cell exosomes and lipidosome and modifying honey polysaccharide, and the pulsatilla chinensis exosome compound is loaded with interleukin 23 peptidomimetic, polyethylene glycol, black scale quantum dots and camptothecin. The composition has the functions of efficient anti-inflammation, immunoregulation, precise targeting and tissue repair, and meanwhile, the curative effect is enhanced through photo-thermal synergistic treatment. The preparation method comprises the steps of exosome extraction by a density gradient centrifugation method, liposome fusion and surface modification. The composition is suitable for treating mucosal inflammation such as inflammatory bowel disease and oral mucositis, has the advantages of high stability, good biocompatibility and the like, and provides a safe and effective novel treatment strategy for clinic.
Owner:SHANGHAI PURUI BIOTECHNOLOGY CO LTD

Supramolecular hydrogel and microneedle patch for treating oral mucositis as well as preparation method and application of supramolecular hydrogel and microneedle patch

The invention discloses supramolecular hydrogel and microneedle patch for treating oral mucositis and a preparation method and application thereof, and belongs to the technical field of biological medicine, and the supramolecular hydrogel for treating oral mucositis comprises the following raw materials: guanosine, a potassium hydroxide solution containing metal ion soluble salt and phenylboronic acid lactone drugs. The raw material of the microneedle patch further comprises a water-soluble backing solution. The supramolecular hydrogel or microneedle patch for treating oral mucositis integrates antibacterial, anti-inflammatory, antioxidant and angiogenesis promoting functions, and has a remarkable effect of promoting healing of chemotherapeutic oral mucosal lesion.
Owner:SHANGHAI FOURTH PEOPLES HOSPITAL

Traditional Chinese medicine compound composition with effect of preventing and treating radioactive injury as well as preparation method and application of traditional Chinese medicine compound composition

The invention discloses a traditional Chinese medicine compound composition with an effect of preventing and treating radioactive injury as well as a preparation method and application thereof. The traditional Chinese medicine compound composition is prepared from 5-15 parts of American ginseng, 3-6 parts of sea-buckthorn and 10-30 parts of rhizoma polygonati. The composition is proportioned and optimized according to the theory of treatment based on syndrome differentiation, and the medicines are combined to achieve the effects of tonifying qi, activating blood and nourishing yin. Clinical experiment results show that the traditional Chinese medicine compound composition provided by the invention has a remarkable effect of preventing and treating radioactive injury, particularly has a remarkable curative effect in the aspects of improving oral mucositis, dry mouth, weakness, sleep disorder and the like after radiotherapy, and is safe in clinical medication.
Owner:JIANGSU PROVINCIAL HOSPITAL OF TCM

Construction method of model for predicting risk of complicated oral mucositis during hematopoietic stem cell transplantation of leukemia patient

The invention discloses a construction method of a leukemia patient hematopoietic stem cell transplantation concurrent oral mucositis risk prediction model, which comprises the following steps: estimating a sample size by adopting an EPV principle, and collecting enough acute leukemia patients for hematopoietic stem cell transplantation treatment cases, basic information, clinical symptoms, hematology indexes and outcome indexes including cases are collected, data arrangement and statistical analysis are carried out by using SAS9.4, risk factors are obtained, and Plt; and the risk factor variable of 0.05 is incorporated into a multi-factor Cox regression model, a risk prediction model is constructed, and visualization is realized. Through verification, the model is stable. The data source of the model has the characteristics of being easy to obtain, objective in index and small in influence on patients, and the model is more suitable for clinical first-line medical staff to monitor oral mucositis.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY

Pharmaceutical kit for alleviating adverse effects of chemotherapy

ActiveUS12797434B2DiseaseNausea sickness
The present disclosure relates to a pharmaceutical kit for alleviating adverse effects of chemotherapy, reducing oxidative stress, improving immunomodulatory response and quality of life. The pharmaceutical kit comprises Suvarna bhasmadi Vati (SBD), Mouktikyukta Kamdudha Vati (MKD), Padmakadi Ghrut (PDG), and Ananta vati. The pharmaceutical kit of the present disclosure can be used for alleviating adverse effects of chemotherapy such as nausea, vomiting, anorexia, fever, taste alteration, fatigue, dyspepsia, and mucositis. It can also improve immune status and reduce oxidative stress leading to betterment of the quality of life of the patients treated with chemotherapy. The pharmaceutical kit of the present disclosure may be beneficial in cancers and diseases for which chemotherapy is a treatment of choice.
Owner:SARDESHMUKH SADANAND PRABHAKAR

Traditional Chinese medicine compound, preparation method and application of traditional Chinese medicine compound in preparation of medicine for preventing or treating digestive tract mucositis caused by targeted medicine

The invention discloses a traditional Chinese medicine compound for preventing or treating digestive tract mucositis caused by targeted drugs, which is prepared from the following components in parts by weight: 2-4 parts of fructus evodiae, 5-7 parts of marmor serpentinatum, 5-7 parts of geranium wilfordii, 5-7 parts of persimmon frost and 2-4 parts of rhizoma kaempferiae, preferably 3: 6: 6: 6: 3. The preparation method is water decoction and concentration. The compound has the effects of eliminating cold to stop pain, supporting yang to stop diarrhea, dispersing blood stasis, stopping bleeding and the like, obviously reduces the index of diarrhea caused by TKI and the score of oral mucositis, and is suitable for complication management of targeted therapy of NSCLC patients in the stage IV. An orthogonal test verifies scientificity of the formula, and the formula has safety and effectiveness.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

Treatment of oral mucositis induced by cancer therapy

Provided are Streptococcus salivarius and compositions comprising Streptococcus salivarius for the treatment of ENT diseases, in particular cancer therapy-induced oral mucositis and respiratory tract infections associated with cancer therapy.
Owner:BACTO PHARMACEUTICAL CO LTD

Coating composition for treating or preventing periimplantitis and preparation method thereof

The present invention relates to a method for preparing a coating composition comprising an anti-infective agent for the controlled release of said anti-infective agent, and to a coating composition or coated substrate obtainable by said method. Such coating compositions are particularly useful in the dental field for the treatment or prevention of inflammatory processes, such as mucositis or peri-implantitis, preferably peri-implantitis.
Owner:JAIME I UNIV +1

Polypeptide and application thereof

The invention relates to the technical field of medicine, in particular to polypeptide and application thereof in preparation of medicine for treating oral mucosa diseases. The polypeptide disclosed by the invention can be used for treating recurrent aphthous oral ulceration and oral mucositis caused by anti-tumor treatment. The polypeptide disclosed by the invention has a remarkable treatment effect, can promote ulcer healing, and is dose-dependent and time-dependent; the polypeptide is high in safety, a degradation product is natural amino acid, and the polypeptide has a wide application prospect.
Owner:ZHEJIANG ECHON BIOMEDICAL CO LTD

Development of amyloglucosidase as a medicinal food or dietary supplement

Embodiments of the disclosure include particular amyloglucosidase (AMG) compositions formulated as a nutriceutical or medicinal food, for example. The AMG compositions are formulated at a specific dosage and / or are lacking in one or more toxins or have substantially reduced levels of toxin, such as deoxynivalenol (vomit toxin). The AMG compositions are provided to individuals in need thereof, such as an individual with or at risk for congenital sucrase isomaltase syndrome, functional bowel disorders, small bowel bacterial overgrowth, protein-calorie malnutrition (marasmus), radiochemotherapy-induced mucositis and / or short-gut syndrome.
Owner:BAYLOR COLLEGE OF MEDICINE

Cold compress patch

The utility model discloses a cold compress patch, and belongs to the technical field of medical supplies. Comprising a cheek cold compress unit, a throat cold compress unit and hangers, the hangers are arranged at the left end and the right end of the cheek cold compress unit respectively, the throat cold compress unit is arranged at the lower end of the cheek cold compress unit, and the cheek cold compress unit and the throat cold compress unit are each of a three-layer structure composed of a backing layer, a hydrogel layer and a skin-friendly film layer. A lip avoiding opening is formed in the cheek cold compress unit; when hematopoietic stem cell transplantation is carried out in a laminar flow clean ward, local cooling can be conveniently carried out on the cheeks on the two sides and the throat and pharynx to prevent oral mucositis caused by chemotherapeutic drugs, meanwhile, the size of the structure can be adjusted according to different patients, operation of medical and health personnel is facilitated, and the use comfort level is improved.
Owner:HUNAN PROVINCIAL PEOPLES HOSPITAL

Mucoadhesive microgel compositions and methods for using the same

Mucoadhesive microgel compositions, which include an active agent (such as HB-EGF), are provided. Aspects of the invention include a microgel comprising a crosslinked poly(ethylene glycol) methyl ether methacrylate polymer comprising a mucoadhesive functionality. Also provided are methods of making and using the mucoadhesive microgel compositions, e.g., in therapeutic applications. In one embodiment, HB-EGF loaded mucoadhesive microgel compositions are provided, e.g., for prevention or treatment of mucositis conditions, such as therapy induced oral mucositis conditions.
Owner:CENT NAT DE LA RECH SCI (C N R S) +1

Oral mucosa treatment formulations

Composition for use for the treatment and / or prevention of infections or lesions of the (oral) mucosa, in particular originating from at least one selected the group consisting of: perleche; scarlet fever; pharyngitis; acute necrotising ulcerative mucositis; impetigo contagiosa; chelitis glandularis apostem atosa; gingivostomatitis herpetica; herpes simplex; herpes stabistis recidivans; herpes zoster; hand-foot-mouth; human papilloma virus; HIV; oral candidiasis; oral lichen planus; lichen ruber planus; leukoplakia, erythroplakia; methicillin-resistant staphylococcus aureus; gingivitis / periodontitis; mucositis / peri- implantitis; alveolar osteolytis; wherein the composition comprises or consists of the following components: (a) polyhexanide (PHMB); (b) an organic or inorganic buffer different from a); (c) further additives; (d) optionally water.
Owner:THOMMEN MEDICAL

Biological polysaccharide having effect of preventing and treating hormone-dependent dermatitis and application thereof

A composition contains β-glucan and is used for preventing and / or treating hormone-dependent dermatitis, skin mucositis or other skin inflammatory diseases.
Owner:ZHEJIANG GLLION BIOTECH CO LTD

Cream for promoting healing of oral mucosa skin

The invention relates to the technical field of oral cavity and skin health care, and particularly discloses a cream for promoting oral mucosa skin healing, the cream comprises the following raw materials by weight: 5-10% of a functional component, 5-10% of a repairing component, 5-8% of an emulsifier, 3-5% of a stabilizer, 20-30% of a matrix, and the balance deionized water; the functional component comprises a kiwi fruit extracting solution; the repairing component comprises hyaluronic acid; the emulsifier is mixed stearate; the technical problems that an existing cream is single in function, and complex requirements of multiple stages and multiple targets in the oral mucosa and skin healing process are difficult to meet at the same time are solved; the obtained cream can be simultaneously suitable for healing of skin and oral mucosa, and is suitable for healing of skin wounds such as burns, scalds, scratches and the like; treating dermatitis, eczema and other skin inflammations; the traditional Chinese medicine composition can be used for treating oral mucosa such as oral ulcer, oral mucositis, thrush, erosive oral lichen planus and the like, and has a wide application prospect.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Application of sitagliptin in preparation of medicine for treating and / or preventing radiation-induced oral mucositis

The invention discloses application of sitagliptin in preparation of a medicine for treating and / or preventing radiation-induced oral mucositis, and belongs to the technical field of biological pharmacy, and the medicine contains sitagliptin with a treatment effective amount and a pharmaceutically acceptable carrier and / or excipient. The application of sitagliptin in treatment and / or prevention of radiation-induced oral mucositis is provided for the first time, the sitagliptin has the advantages of being good in treatment effect, good in safety and the like, and the problem of treatment of radiation-induced oral mucositis is solved.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Agaricus blazei murill extract and application thereof in treating intestinal mucositis

The invention belongs to the technical field of medicines, and particularly relates to an agaricus blazei murill extract and application thereof in treating intestinal mucositis. The invention provides application of an agaricus blazei murill extract FA-2-b-beta in preparation of a medicine for preventing, treating and / or relieving intestinal mucositis. The FA-2-b-beta can obviously improve 5-FU induced intestinal mucositis, obviously promote human intestinal epithelial cell proliferation, recover intestinal barriers and resist toxic and side effects of chemotherapy.
Owner:KANGZHEN BIOTECHNOLOGY (BEIJING) CO LTD +1

Traditional Chinese medicine composition for treating chemotherapy-related oral mucositis and preparation method and application thereof

PendingCN121927001ACompatibility scienceReflect the idea of ​​compatibilityAntipyreticHydroxy compound active ingredientsScrophulariaForsythia
The invention discloses a traditional Chinese medicine composition for treating chemotherapy-related oral mucositis and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 6-12 parts of radix rehmanniae recen, 6-12 parts of radix ophiopogonis, 6-12 parts of radix scrophulariae, 6-12 parts of honeysuckle, 6-12 parts of fructus forsythiae, 3-7 parts of radix scutellariae, 1-3 parts of lotus plumule, 3-7 parts of mint and 3-7 parts of borneol. The composition has the effects of nourishing yin, clearing heat, astringing sores and promoting tissue regeneration, and clinical tests prove that the composition can remarkably reduce the occurrence rate of chemotherapy-related oral mucositis of hematological malignancy patients, relieve the damage degree of oral mucosa, shorten the lasting time of ulcer and pain and effectively improve clinical symptoms of traditional Chinese medicine, and is high in safety.
Owner:THE FIRST AFFILIATED HOSPITAL OF TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE

Application of aconite polysaccharide in preparing medicine for treating inflammatory bowel disease and intestinal mucositis

The present invention relates to the field of medical technology, and discloses the use of aconite polysaccharide in the preparation of drugs for treating inflammatory bowel disease and intestinal mucositis. The present invention conducts a series of studies on aconite polysaccharide using a mouse model, and finds that aconite polysaccharide can significantly improve the intestinal microbial diversity of mice, and at the same time, can improve intestinal flora disorder and make it tend to normal, and provides a new use of aconite polysaccharide-the use in the preparation of drugs for treating inflammatory bowel disease and intestinal mucositis. For example, aconite polysaccharide is used for drug treatment of ulcerative colitis mouse model and 5-Fu-induced intestinal mucositis mouse model, and both can significantly improve their pathological damage.
Owner:THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE

Dendrobium huoshanense compound granule as well as preparation method and quality detection method thereof

The invention discloses dendrobium huoshanense compound granules as well as a preparation method and a quality detection method thereof, and belongs to the technical field of traditional Chinese medicine preparations. Dendrobium huoshanense, radix rehmanniae recen, radix ophiopogonis and liquorice are used as a formula, granules are selected as a medicine carrying form, the advantages of maintaining property and flavor tropism of each medicine, mainly treating functions, being relatively large in medicine carrying capacity, easy to dissolve, quick in effect taking and simple and convenient in process are exerted, and a decoction process, a concentration drying process and a granulation process in pharmacy are optimized; the preparation method which is simple and convenient in granulation, high in yield and high in stability is obtained, and the obtained compound granules are uniform in granules, small in angle of repose and relatively good in flowability. Quality control experiment results show that the dendrobium huoshanense compound granules prepared according to the preparation method provided by the invention are high in content of effective components such as total flavonoids and rehmannia D, the process is stable, and technical support is provided for treatment of oral mucositis.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Effective part of rosa laevigata for chemoradiotherapy-induced oral mucositis and production process of effective part

The invention discloses an effective part for chemoradiotherapy-induced oral mucositis in traditional Chinese medicinal material white flower and a preparation process of the effective part. The effective part is identified as a flavonoid component through standard substance spectrogram comparison. Tests prove that the production process of the effective part is practical and feasible, and the total flavonoids in the finally obtained extracting solution are greater than or equal to 50%. Besides, pharmacodynamic studies show that the effective part has a remarkable bacteriostasis effect on staphylococcus aureus, escherichia coli and candida albicans, the bacteriostasis rate is larger than or equal to 80%, the effective part has a remarkable treatment effect on rat oral mucosa acute inflammation caused by chemoradiotherapy, and the application prospect of the effective part in the adaptation disease is shown.
Owner:NANJING SANTONG PHARM TECH CO LTD

Spray containing taurine and application thereof

The invention relates to application of a composition taking taurine as a main active ingredient in preparation of a medicine for promoting mucous membrane healing. Water is used as a solvent, the taurine oral liquid contains 0.1 wt%-40wt% of taurine, 0.01 wt%-1wt% of amino acid, 0.01 wt%-0.5 wt% of vitamin, a protective agent, a bacteriostatic agent, a preservative, a swelling and pain relieving agent and the like. Through verification, the composition disclosed by the invention is prepared into oral spray, fine mist particles of 10-70 microns generated by a spray instrument show a good treatment effect on radiation-induced oral mucositis, and also have a good healing promoting effect on normal oral mucosa tissues after an alveolar surgery.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Oral mucositis prevention gargling device for patient

The invention discloses an oral mucositis prevention gargling device for a patient, and relates to the technical field of medical instruments, the oral mucositis prevention gargling device comprises a liquid storage unit composed of a first cylinder and a second cylinder; the liquid conveying pump is mounted at the inner bottom of the first cylinder body and is connected to the gargling spray head through a liquid conveying pipeline; wherein a sealing disc is arranged in the second cylinder body, and the sealing disc divides the interior of the second cylinder body into an upper functional chamber and a lower negative pressure chamber; the four-way pipe is mounted on a top plate of the second barrel; the negative pressure pump is mounted in the negative pressure cavity and connected to the first connector of the four-way pipe through a negative pressure pipeline; the partition plate is fixed to the top of the sealing disc and divides the functional cavity into a washing cavity on one side and a collecting cavity on the other side, through the designed backwashing device, backwashing can be conducted on a pipeline, accumulated impurities are removed, the pipeline is recovered to be smooth, the blocking risk is reduced, and the continuity of the treatment process is guaranteed.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE